These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 29595367)
1. Lessons learned from the implementation of a medically enhanced residential treatment (MERT) model integrating intravenous antibiotics and residential addiction treatment. Englander H; Wilson T; Collins D; Phoutrides E; Weimer M; Korthuis PT; Calcagni J; Nicolaidis C Subst Abus; 2018; 39(2):225-232. PubMed ID: 29595367 [TBL] [Abstract][Full Text] [Related]
2. In-hospital illicit drug use, substance use disorders, and acceptance of residential treatment in a prospective pilot needs assessment of hospitalized adults with severe infections from injecting drugs. Fanucchi LC; Lofwall MR; Nuzzo PA; Walsh SL J Subst Abuse Treat; 2018 Sep; 92():64-69. PubMed ID: 30032946 [TBL] [Abstract][Full Text] [Related]
3. VA residential substance use disorder treatment program providers' perceptions of facilitators and barriers to performance on pre-admission processes. Ellerbe LS; Manfredi L; Gupta S; Phelps TE; Bowe TR; Rubinsky AD; Burden JL; Harris AH Addict Sci Clin Pract; 2017 Apr; 12(1):10. PubMed ID: 28372579 [TBL] [Abstract][Full Text] [Related]
4. Impact of implementing a tobacco and recreational nicotine-free policy and enhanced treatments on programmatic and patient-level outcomes within a residential substance use disorder treatment program. Hemmy Asamsama O; Miller SC; Silvestri MM; Bonanno C; Krondilou K J Subst Abuse Treat; 2019 Dec; 107():44-49. PubMed ID: 31757264 [TBL] [Abstract][Full Text] [Related]
5. Smoking and Tobacco-Free Policies in Women's Residential Substance Use Disorder Treatment Facilities: A Community-Engaged Approach. Fallin-Bennett A; Parker KA; Miller A; Ashford K; Hahn EJ Nicotine Tob Res; 2018 Sep; 20(11):1386-1392. PubMed ID: 29059449 [TBL] [Abstract][Full Text] [Related]
6. Residential addiction treatment for injection drug users requiring intravenous antibiotics: a cost-reduction strategy. Jewell C; Weaver M; Sgroi C; Anderson K; Sayeed Z J Addict Med; 2013; 7(4):271-6. PubMed ID: 23648642 [TBL] [Abstract][Full Text] [Related]
7. 'It opened my eyes, my ears, and my heart': Codesigning a substance use disorder treatment programme. Bosak J; Drainoni ML; Bryer C; Goodman D; Messersmith L; Declercq E Health Expect; 2024 Feb; 27(1):e13908. PubMed ID: 37920874 [TBL] [Abstract][Full Text] [Related]
8. Impacts of COVID-19 on residential treatment programs for substance use disorder. Pagano A; Hosakote S; Kapiteni K; Straus ER; Wong J; Guydish JR J Subst Abuse Treat; 2021 Apr; 123():108255. PubMed ID: 33375986 [TBL] [Abstract][Full Text] [Related]
9. Outpatient continuing care after residential substance use disorder treatment in the US Veterans Health Administration: Facilitators and challenges. Rubinsky AD; Ellerbe LS; Gupta S; Phelps TE; Bowe T; Burden JL; Harris AHS Subst Abus; 2018; 39(3):322-330. PubMed ID: 29043947 [TBL] [Abstract][Full Text] [Related]
10. Safety and psychological impact of sailing adventure therapy among Veterans with substance use disorders. Marchand WR; Klinger W; Block K; VerMerris S; Herrmann TS; Johnson C; Shubin E; Sheppard S Complement Ther Med; 2018 Oct; 40():42-47. PubMed ID: 30219467 [TBL] [Abstract][Full Text] [Related]
11. Inpatient hospitalization for substance use disorders one year after residential rehabilitation: predictors among US veterans. Chang G; Martin KB; Tang M; Fleming JA Am J Drug Alcohol Abuse; 2016; 42(1):56-62. PubMed ID: 26485005 [TBL] [Abstract][Full Text] [Related]
12. Integrating comprehensive hepatitis C virus care within a residential substance use disorder treatment program. Burton MJ; Voluse AC; Anthony V J Subst Abuse Treat; 2019 Mar; 98():9-14. PubMed ID: 30665610 [TBL] [Abstract][Full Text] [Related]
13. Mitigation of Covid-19 infection in substance use disorder residential settings. Fareed A; Fareed M J Addict Dis; 2021; 39(1):140-143. PubMed ID: 33036545 [TBL] [Abstract][Full Text] [Related]
15. Timely linkage of individuals to substance use disorder treatment: development, implementation, and evaluation of FindHelpNowKY.org. Bunn TL; Quesinberry D; Jennings T; Kizewski A; Jackson H; McKee S; Eustice S BMC Public Health; 2019 Feb; 19(1):177. PubMed ID: 30744608 [TBL] [Abstract][Full Text] [Related]
16. "OPTIONS-DC", a feasible discharge planning conference to expand infection treatment options for people with substance use disorder. Sikka MK; Gore S; Vega T; Strnad L; Gregg J; Englander H BMC Infect Dis; 2021 Aug; 21(1):772. PubMed ID: 34372776 [TBL] [Abstract][Full Text] [Related]
17. Home self-administration of intravenous antibiotics as part of an outpatient parenteral antibiotic therapy service: a qualitative study of the perspectives of patients who do not self-administer. Tonna A; Anthony G; Tonna I; Paudyal V; Forbes-McKay K; Laing R; Mackenzie A; Falconer S; McCartney G; Stewart D BMJ Open; 2019 Jan; 9(1):e027475. PubMed ID: 30782762 [TBL] [Abstract][Full Text] [Related]
18. Characterizing Multisystem Barriers to Women's Residential SUD Treatment: A Multisite Qualitative Analysis in Los Angeles. Rivera D; Henwood BF; Sussman S; Wenzel S; Dasgupta A; Campbell ANC; Wu E; Amaro H J Urban Health; 2024 Jun; 101(3):653-667. PubMed ID: 38632159 [TBL] [Abstract][Full Text] [Related]
19. Moment-by-Moment in Women's Recovery: Randomized controlled trial protocol to test the efficacy of a mindfulness-based intervention on treatment retention and relapse prevention among women in residential treatment for substance use disorder. Amaro H; Black DS Contemp Clin Trials; 2017 Nov; 62():146-152. PubMed ID: 28918120 [TBL] [Abstract][Full Text] [Related]
20. A Qualitative Assessment of the Treatment Needs of Women with Concurrent Eating and Substance Use Disorders in a Residential Setting. Humphreys E; Ladner T; van Draanen J J Dual Diagn; 2023; 19(2-3):153-165. PubMed ID: 36977186 [No Abstract] [Full Text] [Related] [Next] [New Search]